Abstract:Pyrimidinone scaffolds are present in a wide array of molecules with synthetic and pharmacological utility. The inherent properties of these compounds may be attributed to intermolecular interactions analogous to the interactions that molecules tend to establish with active sites. Pyrimidinones and their fused derivatives have garnered significant interest due to their structural features, which resemble nitrogenous bases, the foundational building blocks of DNA and RNA. Similarly, pyrimidinones are predisposed to forming N-H···O hydrogen bonds akin to nitrogenous bases. Given this context, this study explored the supramolecular features and the predisposition to form hydrogen bonds in a series of 18 substituted 4-(trihalomethyl)-2(1H)-pyrimidinones. The formation of hydrogen bonds was observed in solution via nuclear magnetic resonance (NMR) spectroscopy experiments, and subsequently confirmed in the crystalline solid state. Hence, the 18 compounds were crystallized through crystallization assays by slow solvent evaporation, followed by single-crystal X-ray diffraction (SC-XRD). The supramolecular cluster demarcation was employed to evaluate all intermolecular interactions, and all crystalline structures exhibited robust hydrogen bonds, with an average energy of approximately -21.64 kcal mol-1 (∼19% of the total stabilization energy of the supramolecular clusters), irrespective of the substituents at positions 4, 5, or 6 of the pyrimidinone core. To elucidate the nature of these hydrogen bonds, an analysis based on the quantum theory of atoms in molecules (QTAIM) revealed that the predominant intermolecular interactions are N-H···O (average of -16.55 kcal mol-1) and C-H···O (average of -6.48 kcal mol-1). Through proposing crystallization mechanisms based on molecular stabilization energy data and contact areas between molecules and employing the supramolecular cluster and retrocrystallization concepts, it was determined that altering the halogen (F/Cl) at position 4 of the pyrimidinone nucleus modifies the crystallization mechanism pathway. Notably, the hydrogen bonds present in the initial proposed steps were confirmed by 1H NMR experiments using concentration-dependent techniques.

Crystal Structure Of 2,6-Dimethylpyridinium Hydrogen Fumarate: Hydrogen Bonds Of C(Sp(3))-H Center Dot Center Dot Center Dot O, C(Sp(2))-H Center Dot Center Dot Center Dot O And N+-H Center Dot Center Dot O-(Sp(3))

Crystal Structure of 2,6-Dimethylpyridinium Hydrogen Fumarate: Hydrogen Bonds of C(sp3)–H···O, C(sp2)–H···O and N+–H···O−(sp3)

Bis(3-hydroxypyridinium) Fumarate

2,2′-Diamino-4,4′-bi-1,3-thiazolium Fumarate

The Crystal Structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3

4-Acetylpyridine-fumaric Acid (2/1)

2-Amino-4-methylpyridinium 4-Aminobenzoate

4-{2-[4-(Dimethylamino)phenyl]ethenyl}-1-methylpyridinium 2-amino-3,5-dimethylbenzenesulfonate monohydrate

Crystal structure of 2,6-dimethylpyridinium hydrogen phthalate

Crystal Structure of 2 '-(4-dimethylaminobenzylidene)-2-hydroxy-benzoylhydrazide, (Ch3)(2)n(c6h4)(ch)n(nh)(co)(c6h4oh)

Crystal Structure of 4,4′-(Ethene-1,2-diyl)dipyridinium Bis(3-Carboxybenzenesulfonate)

Structure, DFT calculations, spectroscopic characterization, and solvent-dependent HOMO-LUMO studies of 3-(hydroxymethyl) pyridinium 4-hydroxybenzenesulfonate

Crystal structure and magnetic properties of a nitronyl nitroxide complex {[Co2(NIT4Py)4(fum)2(H2O)4] · (H2O)2}n

F Center Dot Center Dot Center Dot H-N And Meo Center Dot Center Dot Center Dot H-N Hydrogen-Bonding In The Solid States Of Aromatic Amides And Hydrazides: A Comparison Study

Crystal structure of 3-(difluoromethyl)-1-methyl- N -(pyridin-2-yl)-1 H -pyrazole-4-carboxamide, C 11 H 10 F 2 N 4 O

Synthesis and Crystal Structure of Two Cyano-Bridged Dimeric 4F-3D Complexes

4-{2-[4-(Dimethylamino)phenyl]ethenyl}-1-methylpyridinium 3,5-Dicarboxybenzenesulfonate Methanol Monosolvate

The Persistence of Hydrogen Bonds in Pyrimidinones: From Solution to Crystal

Crystal structure of N -(4-bromobenzyl)-3-(difluoromethyl)-1-methyl- N -(pyridin-2-yl)-1 H -pyrazole-4-carboxamide, C 18 H 15 BrF 2 N 4 O

Crystal structure of 6,6′-((1 E ,1′ E )-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C 26 H 26 N 6 O 5

2′,7′-Di-4-pyridylspiro[cyclopropane-1,9′-fluorene] Hemihydrate